Xuenou > Podcasts > FDA advisers back Novavax COVID shots as 4th US option
FDA advisers back Novavax COVID shots as 4th US option
A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults

FDA advisers back Novavax COVID shots as 4th US option

A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults